Atopic Dermatitis Market Size, Share, Trends, Growth, Emerging Technology, Historical Demands by Regional Forecast to 2030

 Overview

Atopic dermatitis is one of the most common but severe types of eczema, which causes red, itchy rash usually on the arms, cheeks, and legs. It makes the patient’s skin and immune system extremely sensitive and reactive to the smallest allergens or irritants.

Atopic dermatitis most commonly affects children and infants, and studies show that in recent years, one of the major causes for its prevalence is air pollution.

According to a report published by Market Research Future (MRFR), the global atopic dermatitis market has been assessed to witness remarkable growth at an 13.20% CAGR over the forecast period of 2022 to 2030.

The global atopic dermatitis market is primarily driven by the growing prevalence of atopic dermatitis, the increasing incidence of food allergies, and the rising level of air pollution.

Additionally, the market in developed countries is growing due to the stable economies, consequently enabling government authorities to invest in the healthcare sector, the availability of the superior quality of healthcare facilities, the high disposable income of consumers leading to the affordability of proper treatments, and the growing investment in research and development for advanced treatment methods of atopic dermatitis.

Regional Analysis

North America is the dominant region in the global atopic incontinence dermatitis treatment market and has been assessed to lead the market over the forecast period, owing to the extensive investment in the healthcare sector, government expenditure towards healthcare research and development for advancement, growing usage of cosmetics and perfumes which lead to skin irritation, and the increasing patient population.

Europe has been accounted for the second largest market share in the global atopic dermatitis market. The market has been assessed to grow significantly due to the increasing expenditure in stable economies such as France and Germany on healthcare and ensures the affordability of  high-quality medical care by consumers owing to their steady disposable income.

The Asia Pacific has been assessed as the fastest growing region in the global atopic dermatitis market, owing to the increasing healthcare expenditure by the governments in emerging economies such as China, and India, to provide consumers with better medical facilities.

The Middle East and Africa region has been assessed to show slow and gradual growth over the forecast period and is expected to register the comparatively smallest market share owing to the underdeveloped healthcare sector in the region and the unstable economies.

Segmental Analysis

The global atopic dermatitis market has been segmented on the basis of type, application, end-user, and region.

Based on type, it is segmented into calcitonin, erythropoietin, hormone, interferon, monoclonal antibodies, and others.

Based on application, the atopic dermatitis market is segmented into blood disorders, cancer, chronic diseases, infectious diseases, and others.

Based on end-users, it is segmented into clinics, hospitals, and research centers.

Atopic Dermatitis Market Players

  • Anacor Pharmaceuticals Inc. (U.S.)
  • Bristol-Myers Squibb (U.S.)
  • Meda Pharmaceuticals (U.S.)
  • Pfizer Inc. (U.S.)
  • Regeneron Pharmaceuticals Inc. (U.S.)
  • Valeant Pharmaceuticals International Inc (Canada)
  • Allergan Plc. (Republic of Ireland)
  • Astellas Pharma Inc. (Japan)
  • Galderma S.A. (Switzerland)
  • Novartis International AG (Switzerland)
  • Sanofi S.A. (France)

among others are some key companies in the global Atopic Dermatitis that are listed by MRFR for market research.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Acute Care EHR Market Focuses on SWOT analysis, Synopsis, Development Plans 2020 to 2027

  Overview The acute care EHR slightly differ from the hospital and ambulatory EHR, generating patient information with all clinical details including the operating room, emergency department, ICU, and inpatient unit. Over the past decade, there has been a significant rise in the number of patients suffering from chronic diseases such as cancer, diabetes, heart disease, and stroke among others which are driving the acute care EHR market, increasing the number of caregiving facilities across the globe. Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come; Market Research Future (MRFR), in its recently published market forecast asserts that the global  acute care EHR market  will grow exponentially by 2023, registering approximately 7% CAGR during the forecast period (2020 – 2027). The global acute care EHR is majorly driven by the augmenting demand for the remote health monitoring for geriatric patient
Read more

mHealth Market Latest Study Focuses On Current, Future Innovations and Top Key Vendors | Forecast 2030

  Market Overview The wave of modernization in the healthcare sector has led to the penetration of the concept of mHealth greatly. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is forecasted to achieve a 36.5% CAGR in the upcoming forecast period. The robust growth pace in the wearable health device sector has increased the expansion of the  mHealth market  globally. Moreover, increased usage of smartphones is also playing a key role in the growth of the market. Also, patients are increasingly involved and aware of their treatments which is expected to further influence the mHealth market in the forecast period. Segmental Analysis The segmental evaluation of the mHealth market is carried out on the basis of therapeutics, applications, and region. On the basis of therapeutics, the mHealth market has been segmented into respiratory,
Read more

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth, Opportunity and Product Developments 2030 |MRFR

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device ma rket . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Regional Analysis The market in the Americas is expected to dominate t
Read more